Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2023-07-05 | Reverse | 1:20 |
Biofrontera Inc. is a Massachusetts-based biopharmaceutical company specializing in dermatological treatments, offering products like Ameluz, RhodoLED lamps, and Xepi for conditions such as actinic keratosis and impetigo.

Ameluz® is a prescription gel used with photodynamic therapy to treat actinic keratoses, serving as Biofrontera's flagship drug with ongoing studies to expand its dermatological applications.
| Icon | PRODUCT | Q2-2024 | Q3-2024 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | License | — | — | $400K | $400K |
![]() | Government and Payor Rebates | $90K | $167K ▲ | — | — |
![]() | Returns | $77K | $78K ▲ | — | — |
![]() | Prompt Pay Discounts | $6K | $6K | — | — |
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
DWTX | $2.31 | COMPARE |
AYTU | $2.25 | COMPARE |
COCP | $1.12 | COMPARE |
TRIB | $9.50 | COMPARE |
GELS | $0.85 | COMPARE |
IMNN | $1.56 | COMPARE |
EVGN | $0.54 | COMPARE |
SBFM | $1.13 | COMPARE |